The majority of antibiotics used globally are administered to farm animals, and evidence...
- Herd health: agriculture’s role in the global AMR crisis
- WHO’s Essential Medicines List: discussing innovation and access
- Can Pharmaoffer become the Amazon of pharma raw materials?
- How automation and man-machine collaboration is reshaping blood storage
- Novartis defends Zolgensma in face of FDA’s data concerns
Herd health: agriculture’s role in the global AMR crisis
The majority of antibiotics used globally are administered to farm animals, and evidence is showing the impact it’s having on the antimicrobial resistance crisis. How does the animal-focused pharma industry feed into AMR in humans, and what are the alternatives to important shared-use antibiotics?
AirBridgeCargo Airlines is Re-Certified for IATA CEIV Pharma
AirBridgeCargo Airlines has successfully gained its IATA CEIV Pharma re-certification following two-day audit procedures for compliance with IATA’s Center of Excellence for Validators in Pharmaceutical Logistics (CEIV Pharma) certification program.
WHO’s Essential Medicines List: discussing innovation and access
Since 1977, the WHO’s Essential Medicines List has provided an important guide to help countries prioritise their own drug procurement. But how does the list operate in the 21st century, and in what ways does it impact the global pharmaceutical industry?
UK’s NAO warns of uncertain medicines supply in no-deal Brexit
A report by the National Audit Office (NAO), UK has warned that a no-deal Brexit still poses a threat to the supply of medicines, indicating the need for more measures to ensure adequate supply.
FDA investigating Zantac for carcinogenic chemicals
Zantac tablets have been found to contain 26,000 times the FDA-approved amount of NDMA (a cancer-causing chemical) that can be safely consumed daily.
Teva Pharmaceuticals to Attain End-to-End Supply Chain Visibility with Kinaxis
Kinaxis Inc, a leader in empowering people to make confident supply chain decisions, has announced it has been selected by Teva Pharmaceuticals to help Teva connect its data, processes and people into a single platform to transform its global supply chain, improve visibility and operational efficiencies and increase customer satisfaction.
Can Pharmaoffer become the Amazon of pharma raw materials?
Disruptions in the supply of the raw materials needed to manufacture medicines are increasingly common. Could the digitisation of the API/excipients marketplace help address the issue? To find out more Abi Millar spoke to Ammar Badwy, co-founder of Dutch start-up Pharmaoffer, which provides a digital platform for drugmakers to connect with qualified material suppliers.
Authorised generics: a poorly known pharma tactic to fend off competition
According to the FDA, there are almost 1,200 authorised generics in the US, and they are currently being approved at a rate of one per week on average.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.